source
- FDA advisory panel backs compounding of unapproved peptides BPC-157 and KPVAn FDA advisory panel voted narrowly to recommend that compounding pharmacies be permitted to produce the unapproved peptides BPC-157 and KPV. The recommendation is seen as a victory for supporter…
- FDA to discontinue pilot program aimed at preventing drug production issuesThe U.S. Food and Drug Administration announced it will end a pilot program that was created to help drug manufacturers address production problems before they arise. The initiative, which ran for…